Cargando…
Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy
The pharmacoenhancement of plasma concentrations of protease inhibitors by coadministration of so-called boosters has been an integral part of antiretroviral therapy for human immunodeficiency virus (HIV) for 1.5 decades. Nearly all HIV protease inhibitors are combined with low-dose ritonavir or cob...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694690/ https://www.ncbi.nlm.nih.gov/pubmed/26730211 http://dx.doi.org/10.2147/HIV.S70836 |